Related Experiment Video
Updated: Jun 29, 2025
06:04
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
384
Early Results With the New Active Bone-Conduction Hearing Implant: A Systematic Review and Meta-Analysis
Alexander Lein1, Wolf-Dieter Baumgartner1, Dominik Riss1
1Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria.
Summary
The new bone conduction implant (BCI) 602 shows excellent audiological outcomes and minimal complications in adults and children with hearing loss. This systematic review confirms its safety and reliability for mixed or conductive hearing loss.
Area of Science:
- Otolaryngology
- Biomedical Engineering
- Audiology
Background:
- The bone conduction implant (BCI) 602 is a novel, smaller transcutaneous device.
- Limited studies exist due to small patient numbers, impacting statistical power.
- This review focuses on early outcomes for mixed or conductive hearing loss.
Purpose of the Study:
- To systematically review and meta-analyze audiological and medical outcomes of the BCI 602.
- To evaluate outcomes in both adult and pediatric patient cohorts.
- To assess the safety and efficacy of the BCI 602.
Main Methods:
- Systematic review and meta-analysis following PRISMA guidelines.
- Inclusion of 6 studies from 108 reviewed.
- Analysis of pre- and postoperative data using fixed-effect and random-effects models.
Main Results:
- 116 patients (64 adults, 52 pediatric) evaluated.
- No intraoperative adverse events; low postoperative complication rates (3.1% adult, 3.8% pediatric).
- Significant improvements in sound field thresholds (MD, -27.05 dB), SNR (MD, -6.35 dB), and word recognition (MD, 68.89%).
Conclusions:
- BCI 602 implantation demonstrates high safety and reliability.
- Excellent audiological outcomes observed in both pediatric and adult groups.
- Further research needed on long-term outcomes and direct comparisons with other BCIs.
